Tag results:

AKT

MicroRNA-766-3p-Mediated Downregulation of HNF4G Inhibits Proliferation in Colorectal Cancer Cells through the PI3K/AKT Pathway

[Cancer Gene Therapy] The authors investigated the role nuclear receptors (NRs) played in colorectal cancer (CRC) pathogenesis. Overexpression of hepatocyte nuclear factor 4 gamma (HNF4G) significantly promoted the proliferation of CRC cells in vitro.

Direct P70S6K1 Inhibition to Replace Dexamethasone in Synergistic Combination with MCL-1 Inhibition in Multiple Myeloma

[Blood Advances] Dexamethasone and the myeloid cell leukemia 1 (MCL-1) inhibitor S63845 proved the most potent combination in a lethality screen and induced apoptosis of human myeloma cell lines that was 50% higher compared with an additive drug effect.

MicroRNA-17 Is a Tumor Suppressor in Oral Squamous Cell Carcinoma and Is Repressed by LSD1

[Oral Diseases] Researchers investigated whether lysine-specific demethylase 1 (LSD1) affected the development of oral squamous cell carcinoma (OSCC) by sustaining the CSCs from OSCC.

M2 Macrophages, but Not M1 Macrophages, Support Megakaryopoiesis by Upregulating PI3K-AKT Pathway Activity

[Signal Transduction and Targeted Therapy] Aberrant bone marrow-M1/M2 MФ polarization, characterized by increased M1 MФs and decreased M2 MФs and accompanied by impaired megakaryopoiesis-supporting abilities, was found in patients with thrombocytopenia post-allotransplant.

Targeting Regulator of G Protein Signaling 1 in Tumor-Specific T Cells Enhances Their Trafficking to Breast Cancer

[Nature Immunology] Scientists found that upregulation of regulator of G protein signaling (RGS)1 in helper TH1 cells and cytotoxic T lymphocytes (CTLs) reduced their trafficking to and survival in tumors and was associated with shorter survival of patients with breast and lung cancer.

Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment

[Cells] Persistent cells were enriched for vimentinhigh sub-population, vimentin knockdown using siRNA approach decreased the invasive and sphere forming capacities as well as Akt phosphorylation in persistent cells, indicating that vimentin was involved in chemotherapeutic treatment-induced enhancement of TNBC aggressiveness.

Popular